David Monteith

David Monteith

Amministratore Delegato presso Audioscenic Ltd.

60 anni
Health Technology
Electronic Technology
Consumer Services

Profilo

David Monteith is the founder of Sonaptic Ltd.
He is currently the Chief Executive Officer of Audioscenic Ltd.
His former jobs include being the Senior Director-Product Value Enhancement at Schering-Plough Corp.
from 2000 to 2009, Managing Director at Sensaura Ltd., Director at Incus Laboratories Ltd.
from 2010 to 2022, Associate VP-Pharmaceutical Development at Merck & Co., Inc. from 2009 to 2014, and Vice President-Research & Development at Avadel Pharmaceuticals Plc from 2014 to 2019.
Dr. Monteith's education includes a graduate degree from Queen's University of Belfast, an undergraduate degree from the University of Strathclyde, and an MBA from Bayes Business School.

Posizioni attive di David Monteith

SocietàPosizioneInizio
Amministratore Delegato -
Tutte le posizioni attive di David Monteith

Precedenti posizioni note di David Monteith

SocietàPosizioneFine
Direttore/Membro del Consiglio 12/01/2022
AVADEL PHARMACEUTICALS PLC Direttore Tecnico/Scientifico/R&S 01/10/2019
MERCK & CO., INC. Corporate Officer/Principal 01/01/2014
Corporate Officer/Principal 01/11/2009
Presidente -
Vedi nel dettaglio l'esperienza di David Monteith

Formazione di David Monteith

Queen's University of Belfast Graduate Degree
University of Strathclyde Undergraduate Degree
Bayes Business School Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David Monteith

Relazioni

100 +

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
MERCK & CO., INC.

Health Technology

AVADEL PHARMACEUTICALS PLC

Health Technology

Aziende private5

Health Technology

Electronic Technology

Retail Trade

Electronic Technology

Electronic Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. David Monteith